Ware RE - Search Results

1

Hemoglobinopathies mimicking Hb S/beta-thalassemia: Hb S/S with alpha-thalassemia and Hb S/Volga.

Luo HY, Heeney M, Wang WC, Eung SH, Ware RE, Steinberg MH, Chui DH. Luo HY, et al. Among authors: ware re. Am J Hematol. 2006 May;81(5):361-5. doi: 10.1002/ajh.20562. Am J Hematol. 2006. PMID: 16628724 Free article.

2

UGT1A promoter polymorphisms influence bilirubin response to hydroxyurea therapy in sickle cell anemia.

Heeney MM, Howard TA, Zimmerman SA, Ware RE. Heeney MM, et al. Among authors: ware re. J Lab Clin Med. 2003 Apr;141(4):279-82. doi: 10.1067/mlc.2003.28. J Lab Clin Med. 2003. PMID: 12677174 Clinical Trial.

3

Increased expression of anti-apoptosis genes in peripheral blood cells from patients with paroxysmal nocturnal hemoglobinuria.

Heeney MM, Ormsbee SM, Moody MA, Howard TA, DeCastro CM, Ware RE. Heeney MM, et al. Among authors: ware re. Mol Genet Metab. 2003 Apr;78(4):291-4. doi: 10.1016/s1096-7192(03)00047-7. Mol Genet Metab. 2003. PMID: 12706380

4

Childhood autoimmune cytopenia secondary to unsuspected common variable immunodeficiency.

Heeney MM, Zimmerman SA, Ware RE. Heeney MM, et al. Among authors: ware re. J Pediatr. 2003 Nov;143(5):662-5. doi: 10.1067/S0022-3476(03)00445-1. J Pediatr. 2003. PMID: 14615742

5

Chemical and functional analysis of hydroxyurea oral solutions.

Heeney MM, Whorton MR, Howard TA, Johnson CA, Ware RE. Heeney MM, et al. Among authors: ware re. J Pediatr Hematol Oncol. 2004 Mar;26(3):179-84. doi: 10.1097/00043426-200403000-00007. J Pediatr Hematol Oncol. 2004. PMID: 15125610

6

Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study.

Hankins JS, Ware RE, Rogers ZR, Wynn LW, Lane PA, Scott JP, Wang WC. Hankins JS, et al. Among authors: ware re. Blood. 2005 Oct 1;106(7):2269-75. doi: 10.1182/Blood-2004-12-4973. Blood. 2005. PMID: 16172253 Free PMC article. Clinical Trial.

7

Beta-thalassemia intermedia due to compound heterozygosity for two beta-globin gene promoter mutations, including a novel TATA box deletion.

Basran RK, Reiss UM, Luo HY, Ware RE, Chui DH. Basran RK, et al. Among authors: ware re. Pediatr Blood Cancer. 2008 Feb;50(2):363-6. doi: 10.1002/pbc.20916. Pediatr Blood Cancer. 2008. PMID: 16732578

8

Preservation of spleen and brain function in children with sickle cell anemia treated with hydroxyurea.

Hankins JS, Helton KJ, McCarville MB, Li CS, Wang WC, Ware RE. Hankins JS, et al. Among authors: ware re. Pediatr Blood Cancer. 2008 Feb;50(2):293-7. doi: 10.1002/pbc.21271. Pediatr Blood Cancer. 2008. PMID: 17554794

9

Hydroxyurea for children with sickle cell disease.

Heeney MM, Ware RE. Heeney MM, et al. Among authors: ware re. Pediatr Clin North Am. 2008 Apr;55(2):483-501, x. doi: 10.1016/j.pcl.2008.02.003. Pediatr Clin North Am. 2008. PMID: 18381097 Review.

10

Microarray analysis of liver gene expression in iron overloaded patients with sickle cell anemia and beta-thalassemia.

Flanagan JM, Steward S, Hankins JS, Howard TM, Neale G, Ware RE. Flanagan JM, et al. Among authors: ware re. Am J Hematol. 2009 Jun;84(6):328-34. doi: 10.1002/ajh.21407. Am J Hematol. 2009. PMID: 19384939 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

378 results

Search Page

Filters